Sonoma Pharmaceuticals
SNOA
#10238
Rank
NZ$8.72 M
Marketcap
$5.40
Share price
-12.25%
Change (1 day)
18.64%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2024 (TTM): -NZ$7.46 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are NZ$13.97 Million. a decrease over its 2023 earnings that were of -NZ$7.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$7.83 Million0.54%
2023 -NZ$7.79 Million-31.5%
2022 -NZ$11.37 Million16.86%
2021 -NZ$9.73 Million194.32%
2020 -NZ$3.31 Million-58.76%
2019 -NZ$8.02 Million-65.66%
2018 -NZ$23.34 Million4.84%
2017 -NZ$22.26 Million-2.17%
2016 -NZ$22.76 Million32.12%
2015 -NZ$17.22 Million-307.74%
2014 NZ$8.28 M-197.5%
2013 -NZ$8.51 Million
2010 -NZ$13.29 Million-14.02%
2009 -NZ$15.46 Million-57.28%
2008 -NZ$36.17 Million-8.03%
2007 -NZ$39.33 Million3.85%
2006 -NZ$37.87 Million39.31%
2005 -NZ$27.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$31.85 Million 306.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.21 Billion 2,540.40%๐Ÿ‡บ๐Ÿ‡ธ USA